Briefsafety
Two children died from gene therapies in China: where the field goes next
Strengthened laws should help to ensure future deaths are quickly disclosed to the public, but China’s reputation for such research is at risk. The deaths of two children in separate gene-editing trials in China raise serious questions about oversight and could have a profound effect on the country’s biomedical industry, say researchers, ethicists and legal scholars [1].
scienceworldstudentsreviews
Sources
This is the neutral brief the press writes once, for everyone, before each reader’s paper adds its own so-what. It links out; it does not republish. 1 article clustered.